APO Research

APO RESEARCH · REPORT

Peptic Ulcers Treatment

Selected research

Market Structure

Global Peptic Ulcers Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Peptic Ulcers Treatment market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Peptic Ulcers Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Peptic Ulcers Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Peptic Ulcers Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Peptic Ulcers Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Peptic Ulcers Treatment include Ache Laboratorios Farmaceuticos S/A, Astellas Pharma Inc., ChoDang Pharm Co., Ltd., Daewoong Pharmaceutical Co., Ltd., Kukje Pharmaceutical Industry Co., Ltd., RaQualia Pharma Inc., Sequella, Inc., Sihuan Pharmaceutical Holdings Group Ltd. and Sinil Pharmaceutical Co., Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Peptic Ulcers Treatment market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Peptic Ulcers Treatment and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Peptic Ulcers Treatment sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Peptic Ulcers Treatment market size, projected growth trends, production technologies, key applications, and end-use industries.

Peptic Ulcers Treatment Segment by Company

Ache Laboratorios Farmaceuticos S/A

Astellas Pharma Inc.

ChoDang Pharm Co., Ltd.

Daewoong Pharmaceutical Co., Ltd.

Kukje Pharmaceutical Industry Co., Ltd.

RaQualia Pharma Inc.

Sequella, Inc.

Sihuan Pharmaceutical Holdings Group Ltd.

Sinil Pharmaceutical Co., Ltd

Yooyoung Pharmaceutical Co., Ltd

Peptic Ulcers Treatment Segment by Type

DWP-14012

DWJ-206

BGC-001

ASP-6537

Others

Peptic Ulcers Treatment Segment by Application

Hospital

Clinic

Others

Peptic Ulcers Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peptic Ulcers Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Peptic Ulcers Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peptic Ulcers Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Peptic Ulcers Treatment market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Peptic Ulcers Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Peptic Ulcers Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Peptic Ulcers Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Peptic Ulcers Treatment Industry Trends Table 2. Peptic Ulcers Treatment Industry Drivers Table 3. Peptic Ulcers Treatment Industry Opportunities and Challenges Table 4. Peptic Ulcers Treatment Industry Restraints Table 5. Global Peptic Ulcers Treatment Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Peptic Ulcers Treatment Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Peptic Ulcers Treatment Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Peptic Ulcers Treatment Sales Market Share by Manufacturers Table 9. Global Peptic Ulcers Treatment Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Peptic Ulcers Treatment Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Peptic Ulcers Treatment Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Peptic Ulcers Treatment Manufacturers, Product Type & Application Table 13. Global Peptic Ulcers Treatment Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Peptic Ulcers Treatment by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of DWP-14012 Table 17. Major Manufacturers of DWJ-206 Table 18. Major Manufacturers of BGC-001 Table 19. Major Manufacturers of ASP-6537 Table 20. Major Manufacturers of Others Table 21. Global Peptic Ulcers Treatment Sales by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Peptic Ulcers Treatment Sales by Type (2021-2026) & (k units) Table 23. Global Peptic Ulcers Treatment Sales by Type (2027-2032) & (k units) Table 24. Global Peptic Ulcers Treatment Sales Market Share by Type (2021-2026) Table 25. Global Peptic Ulcers Treatment Sales Market Share by Type (2027-2032) Table 26. Global Peptic Ulcers Treatment Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 27. Global Peptic Ulcers Treatment Revenue by Type (2021-2026) & (k units) Table 28. Global Peptic Ulcers Treatment Revenue by Type (2027-2032) & (k units) Table 29. Global Peptic Ulcers Treatment Revenue Market Share by Type (2021-2026) Table 30. Global Peptic Ulcers Treatment Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Hospital Table 32. Major Manufacturers of Clinic Table 33. Major Manufacturers of Others Table 34. Global Peptic Ulcers Treatment Sales by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global Peptic Ulcers Treatment Sales by Application (2021-2026) & (k units) Table 36. Global Peptic Ulcers Treatment Sales by Application (2027-2032) & (k units) Table 37. Global Peptic Ulcers Treatment Sales Market Share by Application (2021-2026) Table 38. Global Peptic Ulcers Treatment Sales Market Share by Application (2027-2032) Table 39. Global Peptic Ulcers Treatment Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 40. Global Peptic Ulcers Treatment Revenue by Application (2021-2026) & (k units) Table 41. Global Peptic Ulcers Treatment Revenue by Application (2027-2032) & (k units) Table 42. Global Peptic Ulcers Treatment Revenue Market Share by Application (2021-2026) Table 43. Global Peptic Ulcers Treatment Revenue Market Share by Application (2027-2032) Table 44. Global Peptic Ulcers Treatment Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global Peptic Ulcers Treatment Sales by Region (2021-2026) & (k units) Table 46. Global Peptic Ulcers Treatment Sales Market Share by Region (2021-2026) Table 47. Global Peptic Ulcers Treatment Sales Forecasted by Region (2027-2032) & (k units) Table 48. Global Peptic Ulcers Treatment Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Peptic Ulcers Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. North America Peptic Ulcers Treatment Sales by Country (2021-2026) & (k units) Table 51. North America Peptic Ulcers Treatment Sales by Country (2027-2032) & (k units) Table 52. Europe Peptic Ulcers Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Europe Peptic Ulcers Treatment Sales by Country (2021-2026) & (k units) Table 54. Europe Peptic Ulcers Treatment Sales by Country (2027-2032) & (k units) Table 55. Asia Pacific Peptic Ulcers Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Asia Pacific Peptic Ulcers Treatment Sales by Country (2021-2026) & (k units) Table 57. Asia Pacific Peptic Ulcers Treatment Sales by Country (2027-2032) & (k units) Table 58. South America, Middle East and Africa Peptic Ulcers Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 59. South America, Middle East and Africa Peptic Ulcers Treatment Sales by Country (2021-2026) & (k units) Table 60. South America, Middle East and Africa Peptic Ulcers Treatment Sales by Country (2027-2032) & (k units) Table 61. Global Peptic Ulcers Treatment Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Peptic Ulcers Treatment Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Peptic Ulcers Treatment Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Peptic Ulcers Treatment Revenue Market Share by Region (2021-2026) Table 65. Global Peptic Ulcers Treatment Revenue Market Share by Region (2027-2032) Table 66. Ache Laboratorios Farmaceuticos S/A Company Information Table 67. Ache Laboratorios Farmaceuticos S/A Business Overview Table 68. Ache Laboratorios Farmaceuticos S/A Peptic Ulcers Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Ache Laboratorios Farmaceuticos S/A Peptic Ulcers Treatment Product Portfolio Table 70. Ache Laboratorios Farmaceuticos S/A Recent Development Table 71. Astellas Pharma Inc. Company Information Table 72. Astellas Pharma Inc. Business Overview Table 73. Astellas Pharma Inc. Peptic Ulcers Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Astellas Pharma Inc. Peptic Ulcers Treatment Product Portfolio Table 75. Astellas Pharma Inc. Recent Development Table 76. ChoDang Pharm Co., Ltd. Company Information Table 77. ChoDang Pharm Co., Ltd. Business Overview Table 78. ChoDang Pharm Co., Ltd. Peptic Ulcers Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. ChoDang Pharm Co., Ltd. Peptic Ulcers Treatment Product Portfolio Table 80. ChoDang Pharm Co., Ltd. Recent Development Table 81. Daewoong Pharmaceutical Co., Ltd. Company Information Table 82. Daewoong Pharmaceutical Co., Ltd. Business Overview Table 83. Daewoong Pharmaceutical Co., Ltd. Peptic Ulcers Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Daewoong Pharmaceutical Co., Ltd. Peptic Ulcers Treatment Product Portfolio Table 85. Daewoong Pharmaceutical Co., Ltd. Recent Development Table 86. Kukje Pharmaceutical Industry Co., Ltd. Company Information Table 87. Kukje Pharmaceutical Industry Co., Ltd. Business Overview Table 88. Kukje Pharmaceutical Industry Co., Ltd. Peptic Ulcers Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Kukje Pharmaceutical Industry Co., Ltd. Peptic Ulcers Treatment Product Portfolio Table 90. Kukje Pharmaceutical Industry Co., Ltd. Recent Development Table 91. RaQualia Pharma Inc. Company Information Table 92. RaQualia Pharma Inc. Business Overview Table 93. RaQualia Pharma Inc. Peptic Ulcers Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. RaQualia Pharma Inc. Peptic Ulcers Treatment Product Portfolio Table 95. RaQualia Pharma Inc. Recent Development Table 96. Sequella, Inc. Company Information Table 97. Sequella, Inc. Business Overview Table 98. Sequella, Inc. Peptic Ulcers Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Sequella, Inc. Peptic Ulcers Treatment Product Portfolio Table 100. Sequella, Inc. Recent Development Table 101. Sihuan Pharmaceutical Holdings Group Ltd. Company Information Table 102. Sihuan Pharmaceutical Holdings Group Ltd. Business Overview Table 103. Sihuan Pharmaceutical Holdings Group Ltd. Peptic Ulcers Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Sihuan Pharmaceutical Holdings Group Ltd. Peptic Ulcers Treatment Product Portfolio Table 105. Sihuan Pharmaceutical Holdings Group Ltd. Recent Development Table 106. Sinil Pharmaceutical Co., Ltd Company Information Table 107. Sinil Pharmaceutical Co., Ltd Business Overview Table 108. Sinil Pharmaceutical Co., Ltd Peptic Ulcers Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Sinil Pharmaceutical Co., Ltd Peptic Ulcers Treatment Product Portfolio Table 110. Sinil Pharmaceutical Co., Ltd Recent Development Table 111. Yooyoung Pharmaceutical Co., Ltd Company Information Table 112. Yooyoung Pharmaceutical Co., Ltd Business Overview Table 113. Yooyoung Pharmaceutical Co., Ltd Peptic Ulcers Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. Yooyoung Pharmaceutical Co., Ltd Peptic Ulcers Treatment Product Portfolio Table 115. Yooyoung Pharmaceutical Co., Ltd Recent Development Table 116. Key Raw Materials Table 117. Raw Materials Key Suppliers Table 118. Peptic Ulcers Treatment Distributors List Table 119. Peptic Ulcers Treatment Customers List Table 120. Research Programs/Design for This Report Table 121. Authors List of This Report Table 122. Secondary Sources Table 123. Primary Sources List of Figures Figure 1. Peptic Ulcers Treatment Product Image Figure 2. Global Peptic Ulcers Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Peptic Ulcers Treatment Market Size (2021-2032) & (US$ Million) Figure 4. Global Peptic Ulcers Treatment Sales (2021-2032) & (k units) Figure 5. Global Peptic Ulcers Treatment Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Peptic Ulcers Treatment Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. DWP-14012 Image Figure 9. DWJ-206 Image Figure 10. BGC-001 Image Figure 11. ASP-6537 Image Figure 12. Others Image Figure 13. Global Peptic Ulcers Treatment Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Peptic Ulcers Treatment Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Peptic Ulcers Treatment Sales Market Share by Type (2021-2032) Figure 16. Global Peptic Ulcers Treatment Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 17. Global Peptic Ulcers Treatment Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Peptic Ulcers Treatment Revenue Market Share by Type (2021-2032) Figure 19. Hospital Image Figure 20. Clinic Image Figure 21. Others Image Figure 22. Global Peptic Ulcers Treatment Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Peptic Ulcers Treatment Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Peptic Ulcers Treatment Sales Market Share by Application (2021-2032) Figure 25. Global Peptic Ulcers Treatment Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 26. Global Peptic Ulcers Treatment Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Peptic Ulcers Treatment Revenue Market Share by Application (2021-2032) Figure 28. North America Peptic Ulcers Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 29. North America Peptic Ulcers Treatment Sales Market Share by Country (2021-2032) Figure 30. U.S. Peptic Ulcers Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 31. Canada Peptic Ulcers Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 32. Mexico Peptic Ulcers Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Peptic Ulcers Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 34. Europe Peptic Ulcers Treatment Sales Market Share by Country (2021-2032) Figure 35. Germany Peptic Ulcers Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 36. France Peptic Ulcers Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 37. U.K. Peptic Ulcers Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 38. Italy Peptic Ulcers Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 39. Netherlands Peptic Ulcers Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Peptic Ulcers Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 41. Asia Pacific Peptic Ulcers Treatment Sales Market Share by Country (2021-2032) Figure 42. China Peptic Ulcers Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 43. Japan Peptic Ulcers Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 44. South Korea Peptic Ulcers Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 45. Southeast Asia Peptic Ulcers Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 46. India Peptic Ulcers Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 47. Australia Peptic Ulcers Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Peptic Ulcers Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 49. South America, Middle East and Africa Peptic Ulcers Treatment Sales Market Share by Country (2021-2032) Figure 50. Brazil Peptic Ulcers Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 51. South Africa Peptic Ulcers Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 52. Saudi Arabia Peptic Ulcers Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 53. Turkey Peptic Ulcers Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 54. Argentina Peptic Ulcers Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 55. UAE Peptic Ulcers Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 56. Egypt Peptic Ulcers Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 57. Chile Peptic Ulcers Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 58. Global Peptic Ulcers Treatment Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Peptic Ulcers Treatment Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Peptic Ulcers Treatment Revenue (2021-2032) & (US$ Million) Figure 61. North America Peptic Ulcers Treatment Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Peptic Ulcers Treatment Revenue (2021-2032) & (US$ Million) Figure 63. Europe Peptic Ulcers Treatment Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Peptic Ulcers Treatment Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Peptic Ulcers Treatment Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Peptic Ulcers Treatment Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Peptic Ulcers Treatment Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Peptic Ulcers Treatment Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Peptic Ulcers Treatment Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • DWP-14012
  • DWJ-206
  • BGC-001
  • ASP-6537
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Ache Laboratorios Farmaceuticos S/A
  • Astellas Pharma Inc.
  • ChoDang Pharm Co., Ltd.
  • Daewoong Pharmaceutical Co., Ltd.
  • Kukje Pharmaceutical Industry Co., Ltd.
  • RaQualia Pharma Inc.
  • Sequella, Inc.
  • Sihuan Pharmaceutical Holdings Group Ltd.
  • Sinil Pharmaceutical Co., Ltd
  • Yooyoung Pharmaceutical Co., Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Peptic Ulcers Treatment Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Peptic Ulcers Treatment Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Peptic Ulcers Treatment Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Peptic Ulcers Treatment Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Peptic Ulcers Treatment Market Dynamics
  1. 2.1 Peptic Ulcers Treatment Industry Trends
  2. 2.2 Peptic Ulcers Treatment Industry Drivers
  3. 2.3 Peptic Ulcers Treatment Industry Opportunities and Challenges
  4. 2.4 Peptic Ulcers Treatment Industry Restraints
3 Peptic Ulcers Treatment Market by Manufacturers
  1. 3.1 Global Peptic Ulcers Treatment Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Peptic Ulcers Treatment Sales by Manufacturers (2021-2026)
  3. 3.3 Global Peptic Ulcers Treatment Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Peptic Ulcers Treatment Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Peptic Ulcers Treatment Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Peptic Ulcers Treatment Manufacturers, Product Type & Application
  7. 3.7 Global Peptic Ulcers Treatment Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Peptic Ulcers Treatment Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Peptic Ulcers Treatment Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Peptic Ulcers Treatment Tier 1, Tier 2, and Tier 3
4 Peptic Ulcers Treatment Market by Type
  1. 4.1 Peptic Ulcers Treatment Type Introduction
  2. 4.1.1 DWP-14012
  3. 4.1.2 DWJ-206
  4. 4.1.3 BGC-001
  5. 4.1.4 ASP-6537
  6. 4.1.5 Others
  7. 4.2 Global Peptic Ulcers Treatment Sales by Type
  8. 4.2.1 Global Peptic Ulcers Treatment Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Peptic Ulcers Treatment Sales by Type (2021-2032)
  10. 4.2.3 Global Peptic Ulcers Treatment Sales Market Share by Type (2021-2032)
  11. 4.3 Global Peptic Ulcers Treatment Revenue by Type
  12. 4.3.1 Global Peptic Ulcers Treatment Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Peptic Ulcers Treatment Revenue by Type (2021-2032)
  14. 4.3.3 Global Peptic Ulcers Treatment Revenue Market Share by Type (2021-2032)
5 Peptic Ulcers Treatment Market by Application
  1. 5.1 Peptic Ulcers Treatment Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Peptic Ulcers Treatment Sales by Application
  6. 5.2.1 Global Peptic Ulcers Treatment Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Peptic Ulcers Treatment Sales by Application (2021-2032)
  8. 5.2.3 Global Peptic Ulcers Treatment Sales Market Share by Application (2021-2032)
  9. 5.3 Global Peptic Ulcers Treatment Revenue by Application
  10. 5.3.1 Global Peptic Ulcers Treatment Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Peptic Ulcers Treatment Revenue by Application (2021-2032)
  12. 5.3.3 Global Peptic Ulcers Treatment Revenue Market Share by Application (2021-2032)
6 Global Peptic Ulcers Treatment Sales by Region
  1. 6.1 Global Peptic Ulcers Treatment Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Peptic Ulcers Treatment Sales by Region (2021-2032)
  3. 6.2.1 Global Peptic Ulcers Treatment Sales by Region (2021-2026)
  4. 6.2.2 Global Peptic Ulcers Treatment Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Peptic Ulcers Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Peptic Ulcers Treatment Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Peptic Ulcers Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Peptic Ulcers Treatment Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Peptic Ulcers Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Peptic Ulcers Treatment Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Peptic Ulcers Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Peptic Ulcers Treatment Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Peptic Ulcers Treatment Revenue by Region
  1. 7.1 Global Peptic Ulcers Treatment Revenue by Region
  2. 7.1.1 Global Peptic Ulcers Treatment Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Peptic Ulcers Treatment Revenue by Region (2021-2026)
  4. 7.1.3 Global Peptic Ulcers Treatment Revenue by Region (2027-2032)
  5. 7.1.4 Global Peptic Ulcers Treatment Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Peptic Ulcers Treatment Revenue (2021-2032)
  8. 7.2.2 North America Peptic Ulcers Treatment Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Peptic Ulcers Treatment Revenue (2021-2032)
  11. 7.3.2 Europe Peptic Ulcers Treatment Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Peptic Ulcers Treatment Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Peptic Ulcers Treatment Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Peptic Ulcers Treatment Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Peptic Ulcers Treatment Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Ache Laboratorios Farmaceuticos S/A
  2. 8.1.1 Ache Laboratorios Farmaceuticos S/A Company Information
  3. 8.1.2 Ache Laboratorios Farmaceuticos S/A Business Overview
  4. 8.1.3 Ache Laboratorios Farmaceuticos S/A Peptic Ulcers Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Ache Laboratorios Farmaceuticos S/A Peptic Ulcers Treatment Product Portfolio
  6. 8.1.5 Ache Laboratorios Farmaceuticos S/A Recent Developments
  7. 8.2 Astellas Pharma Inc.
  8. 8.2.1 Astellas Pharma Inc. Company Information
  9. 8.2.2 Astellas Pharma Inc. Business Overview
  10. 8.2.3 Astellas Pharma Inc. Peptic Ulcers Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Astellas Pharma Inc. Peptic Ulcers Treatment Product Portfolio
  12. 8.2.5 Astellas Pharma Inc. Recent Developments
  13. 8.3 ChoDang Pharm Co., Ltd.
  14. 8.3.1 ChoDang Pharm Co., Ltd. Company Information
  15. 8.3.2 ChoDang Pharm Co., Ltd. Business Overview
  16. 8.3.3 ChoDang Pharm Co., Ltd. Peptic Ulcers Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 ChoDang Pharm Co., Ltd. Peptic Ulcers Treatment Product Portfolio
  18. 8.3.5 ChoDang Pharm Co., Ltd. Recent Developments
  19. 8.4 Daewoong Pharmaceutical Co., Ltd.
  20. 8.4.1 Daewoong Pharmaceutical Co., Ltd. Company Information
  21. 8.4.2 Daewoong Pharmaceutical Co., Ltd. Business Overview
  22. 8.4.3 Daewoong Pharmaceutical Co., Ltd. Peptic Ulcers Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Daewoong Pharmaceutical Co., Ltd. Peptic Ulcers Treatment Product Portfolio
  24. 8.4.5 Daewoong Pharmaceutical Co., Ltd. Recent Developments
  25. 8.5 Kukje Pharmaceutical Industry Co., Ltd.
  26. 8.5.1 Kukje Pharmaceutical Industry Co., Ltd. Company Information
  27. 8.5.2 Kukje Pharmaceutical Industry Co., Ltd. Business Overview
  28. 8.5.3 Kukje Pharmaceutical Industry Co., Ltd. Peptic Ulcers Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Kukje Pharmaceutical Industry Co., Ltd. Peptic Ulcers Treatment Product Portfolio
  30. 8.5.5 Kukje Pharmaceutical Industry Co., Ltd. Recent Developments
  31. 8.6 RaQualia Pharma Inc.
  32. 8.6.1 RaQualia Pharma Inc. Company Information
  33. 8.6.2 RaQualia Pharma Inc. Business Overview
  34. 8.6.3 RaQualia Pharma Inc. Peptic Ulcers Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 RaQualia Pharma Inc. Peptic Ulcers Treatment Product Portfolio
  36. 8.6.5 RaQualia Pharma Inc. Recent Developments
  37. 8.7 Sequella, Inc.
  38. 8.7.1 Sequella, Inc. Company Information
  39. 8.7.2 Sequella, Inc. Business Overview
  40. 8.7.3 Sequella, Inc. Peptic Ulcers Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Sequella, Inc. Peptic Ulcers Treatment Product Portfolio
  42. 8.7.5 Sequella, Inc. Recent Developments
  43. 8.8 Sihuan Pharmaceutical Holdings Group Ltd.
  44. 8.8.1 Sihuan Pharmaceutical Holdings Group Ltd. Company Information
  45. 8.8.2 Sihuan Pharmaceutical Holdings Group Ltd. Business Overview
  46. 8.8.3 Sihuan Pharmaceutical Holdings Group Ltd. Peptic Ulcers Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Sihuan Pharmaceutical Holdings Group Ltd. Peptic Ulcers Treatment Product Portfolio
  48. 8.8.5 Sihuan Pharmaceutical Holdings Group Ltd. Recent Developments
  49. 8.9 Sinil Pharmaceutical Co., Ltd
  50. 8.9.1 Sinil Pharmaceutical Co., Ltd Company Information
  51. 8.9.2 Sinil Pharmaceutical Co., Ltd Business Overview
  52. 8.9.3 Sinil Pharmaceutical Co., Ltd Peptic Ulcers Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Sinil Pharmaceutical Co., Ltd Peptic Ulcers Treatment Product Portfolio
  54. 8.9.5 Sinil Pharmaceutical Co., Ltd Recent Developments
  55. 8.10 Yooyoung Pharmaceutical Co., Ltd
  56. 8.10.1 Yooyoung Pharmaceutical Co., Ltd Company Information
  57. 8.10.2 Yooyoung Pharmaceutical Co., Ltd Business Overview
  58. 8.10.3 Yooyoung Pharmaceutical Co., Ltd Peptic Ulcers Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Yooyoung Pharmaceutical Co., Ltd Peptic Ulcers Treatment Product Portfolio
  60. 8.10.5 Yooyoung Pharmaceutical Co., Ltd Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Peptic Ulcers Treatment Value Chain Analysis
  2. 9.1.1 Peptic Ulcers Treatment Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Peptic Ulcers Treatment Production Mode & Process
  6. 9.2 Peptic Ulcers Treatment Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Peptic Ulcers Treatment Distributors
  9. 9.2.3 Peptic Ulcers Treatment Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research